News & Updates

Respiratory-gated PET-CT improves liver tumour imaging

17 Mar 2022 by

A prospective clinical study conducted by the Hong Kong Baptist Hospital in collaboration with the Hong Kong Polytechnic University has demonstrated the feasibility of implementing respiratory-gated PET-CT for liver malignancies with improved image quality compared with ungated scans.

Respiratory-gated PET-CT improves liver tumour imaging

17 Mar 2022

Olaparib-abiraterone combo improves PFS in mCRPC

16 Mar 2022 by

The combination of olaparib and abiraterone in the first-line setting improved radiographic progression-free survival (rPFS) in patients with metastatic castration-resistant prostate cancer (mCRPC), results of the phase III PROpel trial showed.

Olaparib-abiraterone combo improves PFS in mCRPC

16 Mar 2022

Radiotherapy delays do not predict survival, recurrence in oropharynx carcinoma

15 Mar 2022

Treatment delays do not necessarily contribute to cancer-specific survival (CSS) or locoregional recurrence (LRR) in patients with oropharynx carcinoma, reveals a study. However, time on treatment (TOT) of 1 to 3 days is associated with lower CSS.

Radiotherapy delays do not predict survival, recurrence in oropharynx carcinoma

15 Mar 2022

Transgender people less likely to undergo cancer screening

15 Mar 2022

Despite being at increased risk for breast and cervical cancer, transgender people experience inequalities in the uptake of routine cancer screening, a study has found.

Transgender people less likely to undergo cancer screening

15 Mar 2022

Lenvatinib + pembrolizumab improves PFS in East Asian patients with advanced RCC

15 Mar 2022 by

Lenvatinib + pembrolizumab combination regimen improves progression-free survival (PFS) compared with sunitinib in a subset of East Asian patients with advanced renal cell carcinoma (aRCC), a finding that was similar to that of the global population of the CLEAR* trial, according to a subanalysis presented at ASCO GU 2022.

Lenvatinib + pembrolizumab improves PFS in East Asian patients with advanced RCC

15 Mar 2022

Female, non-White oncologists get lower satisfaction scores from patients

14 Mar 2022

Asian and Hispanic oncologists, as well as female oncologists treating genitourinary malignancies, receive lower patient satisfaction scores (PSS), according to a study.

Female, non-White oncologists get lower satisfaction scores from patients

14 Mar 2022

Salvage chemotherapy better than surgery in patients with elevated tumour markers

14 Mar 2022

Salvage chemotherapy is preferable over surgery in patients with alpha-fetoprotein (AFP) >30 µg/l and human chorionic gonadotropin (HCG) ≥20 mIU/ml after first-line chemotherapy, suggests a study.

Salvage chemotherapy better than surgery in patients with elevated tumour markers

14 Mar 2022

Metabolic syndrome tied to risk of 11 cancers

14 Mar 2022

Eleven different malignancies seem to be correlate with metabolic syndrome (MS), as well as with the presence of MS components, reports a recent study.

Metabolic syndrome tied to risk of 11 cancers

14 Mar 2022

PPIs contribute to small increase in pancreatic cancer risk

13 Mar 2022

Individuals exposed to high cumulative doses of proton pump inhibitors (PPIs) have a slightly elevated risk of pancreatic cancer, a study reports.

PPIs contribute to small increase in pancreatic cancer risk

13 Mar 2022

Neoadjuvant chemotherapy worsens survival after breast reconstruction

13 Mar 2022

Neoadjuvant chemotherapy may lead to worse overall survival in women who had undergone mastectomy and immediate breast reconstruction, a recent study has found.

Neoadjuvant chemotherapy worsens survival after breast reconstruction

13 Mar 2022

News & Updates

Filter by Specialty:

Specialty:

Respiratory-gated PET-CT improves liver tumour imaging

Respiratory-gated PET-CT improves liver tumour imaging

Olaparib-abiraterone combo improves PFS in mCRPC

Olaparib-abiraterone combo improves PFS in mCRPC

Radiotherapy delays do not predict survival, recurrence in oropharynx carcinoma

Radiotherapy delays do not predict survival, recurrence in oropharynx carcinoma

Transgender people less likely to undergo cancer screening

Transgender people less likely to undergo cancer screening

Lenvatinib + pembrolizumab improves PFS in East Asian patients with advanced RCC

Lenvatinib + pembrolizumab improves PFS in East Asian patients with advanced RCC

Female, non-White oncologists get lower satisfaction scores from patients

Female, non-White oncologists get lower satisfaction scores from patients

Salvage chemotherapy better than surgery in patients with elevated tumour markers

Salvage chemotherapy better than surgery in patients with elevated tumour markers

Metabolic syndrome tied to risk of 11 cancers

Metabolic syndrome tied to risk of 11 cancers

PPIs contribute to small increase in pancreatic cancer risk

PPIs contribute to small increase in pancreatic cancer risk

Neoadjuvant chemotherapy worsens survival after breast reconstruction

Neoadjuvant chemotherapy worsens survival after breast reconstruction